首页> 外国专利> Cross-linked collagenic peptide for preventing post-surgical adhesions

Cross-linked collagenic peptide for preventing post-surgical adhesions

机译:交联胶原蛋白肽,可防止术后粘连

摘要

The aim of the invention is to provide a modified collagen peptide for preventing post-operative adhesions that is non-toxic, economic, in addition to being easy to obtain, sterilize, manipulate and implement, having controlled biodegradability and presenting a sufficiently strong initial mechanical resistance in situ (cohesion). This is achieved in the case of the modified collagen peptide for preventing post-operative adhesions according to the invention which is characterized in that it comprises at least one collagen peptide that is modified by grafting thiol functions that are free or substituted, cross-linkable and/or at least partly cross-linked, whereby the thiol functions are provided by mercaptoamine radicals that are exclusively grafted on the aspartic and glutamic acids of the collagen chains by means of amide bonds. The modified collagen peptide can exist in the form of a homogeneous or composite film, as a gel or in as a liquid which can be applied and cross-linked per se as on in vivo tissue.
机译:本发明的目的是提供一种用于预防术后粘连的修饰的胶原蛋白肽,该肽不仅无毒,经济,而且易于获得,灭菌,操作和实施,具有可控制的生物降解性,并具有足够强的初始机械性能原位电阻(内聚力)。这在根据本发明的用于防止术后粘连的修饰的胶原蛋白肽的情况下实现,其特征在于其包含至少一种胶原蛋白肽,该胶原蛋白肽通过接枝游离或取代的,可交联的硫醇官能团而修饰。 /或至少部分交联,其中巯基胺基团提供硫醇功能,巯基胺基团仅通过酰胺键接枝在胶原蛋白链的天冬氨酸和谷氨酸上。修饰的胶原蛋白肽可以以均质或复合膜的形式存在,如凝胶或液体形式,其本身可以如在体内组织上施用和交联。

著录项

  • 公开/公告号US6790438B1

    专利类型

  • 公开/公告日2004-09-14

    原文格式PDF

  • 申请/专利权人 FLAMEL TECHNOLOGIES;

    申请/专利号US20020914424

  • 发明设计人 REMI MEYRUEIX;ALAIN CONSTANCIS;

    申请日2002-01-14

  • 分类号A61L310/60;

  • 国家 US

  • 入库时间 2022-08-21 23:19:33

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号